[go: up one dir, main page]

WO2009114202A3 - Vaccine and immunization method using plasmodium antigen 2 - Google Patents

Vaccine and immunization method using plasmodium antigen 2 Download PDF

Info

Publication number
WO2009114202A3
WO2009114202A3 PCT/US2009/001643 US2009001643W WO2009114202A3 WO 2009114202 A3 WO2009114202 A3 WO 2009114202A3 US 2009001643 W US2009001643 W US 2009001643W WO 2009114202 A3 WO2009114202 A3 WO 2009114202A3
Authority
WO
WIPO (PCT)
Prior art keywords
antigen
vaccine
plasmodium antigen
pyag2
pvag2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/001643
Other languages
French (fr)
Other versions
WO2009114202A2 (en
Inventor
Denise Doolan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Navy
Original Assignee
US Department of Navy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Navy filed Critical US Department of Navy
Publication of WO2009114202A2 publication Critical patent/WO2009114202A2/en
Publication of WO2009114202A3 publication Critical patent/WO2009114202A3/en
Priority to US12/881,604 priority Critical patent/US20110229514A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A vaccine comprising an immunogenic preparation containing a Plasmodium antigen or a fragment thereof, wherein said antigen is selected from a group consisting of PyAg2, PfAg2, PvAg2, PkAg2, PoAg2, PmAg2, PbAg2, PcAg2 and a combination thereof. A vaccination method comprising administering a priming immunization preparation containing a Plasmodium antigen or fragment thereof, wherein said antigen is selected from a group consisting of PyAg2, PfAg2, PvAg2, PkAg2, PoAg2, PmAg2, PbAg2, PcAg2 and a combination thereof, and administrating a boosting immunization preparation containing said Plasmodium antigen or fragment, wherein said antigen is selected from a group consisting of PyAg2, PfAg2, PvAg2, PkAg2, PoAg2, PmAg2, PbAg2, PcAg2 and a combination thereof.
PCT/US2009/001643 2008-03-14 2009-03-16 Vaccine and immunization method using plasmodium antigen 2 Ceased WO2009114202A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/881,604 US20110229514A1 (en) 2009-03-16 2010-09-14 Vaccine and immunization method using plasmodium antigen 2

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3666608P 2008-03-14 2008-03-14
US61/036,666 2008-03-14

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/881,604 Continuation-In-Part US20110229514A1 (en) 2009-03-16 2010-09-14 Vaccine and immunization method using plasmodium antigen 2

Publications (2)

Publication Number Publication Date
WO2009114202A2 WO2009114202A2 (en) 2009-09-17
WO2009114202A3 true WO2009114202A3 (en) 2009-12-30

Family

ID=41065740

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/001643 Ceased WO2009114202A2 (en) 2008-03-14 2009-03-16 Vaccine and immunization method using plasmodium antigen 2

Country Status (1)

Country Link
WO (1) WO2009114202A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120244178A1 (en) * 2011-03-25 2012-09-27 Denise Doolan Plasmodium falciparum antigens
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202667A1 (en) * 2002-03-04 2004-10-14 Daniel Carucci Antigens and their use as diagnostics and vaccines against species of plasmodium
US20060147477A1 (en) * 2002-06-11 2006-07-06 Glaxo Group Limited Immunogenic compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202667A1 (en) * 2002-03-04 2004-10-14 Daniel Carucci Antigens and their use as diagnostics and vaccines against species of plasmodium
US20060147477A1 (en) * 2002-06-11 2006-07-06 Glaxo Group Limited Immunogenic compositions

Also Published As

Publication number Publication date
WO2009114202A2 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
Kozak et al. The integrated consideration of vaccine platforms, adjuvants, and delivery routes for successful vaccine development
WO2007022151A3 (en) Immunization of avians by administration of non-replicating vectored vaccines
WO2008021076A3 (en) Protein matrix vaccines and methods of making and administering such vaccines
RU2013104878A (en) LIPOSOMES WITH LIPIDS HAVING THE PREVIOUS VALUE OF RCA FOR RNA DELIVERY
CA2763359C (en) New human rotavirus strains and vaccines
WO2009068992A8 (en) Vaccination with multiple clades of h5 influenza a virus
EA201171032A1 (en) TREATMENT SCHEMES WITH THE HELP OF VACCINE AGAINST FLU, ASSOCIATED WITH PANDEMIC STRAINS
WO2007056266A3 (en) Cd40 ligand fusion protein vaccine
WO2008039874A3 (en) Cancer stem cell antigen vaccines and methods
WO2007092792A3 (en) Yeast-based vaccine for inducing an immune response
MX2010012999A (en) Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof.
TW200722101A (en) Novel composition
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
WO2008057235A3 (en) Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes
WO2006126981A3 (en) Compositions and methods for mucosal vaccination
WO2010037027A3 (en) Immunization of avians by mucosal administration of non-replicating vectored vaccines
UA93508C2 (en) Anti-malaria vaccine
WO2004043399A3 (en) Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines
WO2003059385A3 (en) Hiv vaccine and method of use
EP2329845A4 (en) Avian influenza virus antigen, and booster immunization method for avian influenza vaccine in combination with mucosal adjuvant which is effective through oral administration
WO2009074861A3 (en) Improved vaccine
WO2009114202A3 (en) Vaccine and immunization method using plasmodium antigen 2
AR065765A1 (en) VACCINE COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIOUS DISEASES
WO2003103570A3 (en) TRANSCUTANEOUS IMMUNIZATION AGAINST PAPILLOMAVIRUS WITH A PAPILLOMAVIRUS VIRUS
MX2009011312A (en) Vaccination regimen for b-cell vaccines.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09720827

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09720827

Country of ref document: EP

Kind code of ref document: A2